TipRanks
Immunovant (IMVT)
NASDAQ:IMVT
Want to see IMVT full AI Analyst Report?

Compare Immunovant (IMVT) vs. Competitors

964 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Immunovant
$43.82
$6.03B
-10.34
17.53%
8 Buy
3 Hold
0 Sell
Moderate Buy
TG Therapeutics
$55.42
$9.36B
20.09
79.84%
4 Buy
0 Hold
1 Sell
Moderate Buy
Viridian Therapeutics
$24.18
$2.79B
-6.99
4.27%
12 Buy
0 Hold
0 Sell
Strong Buy
Aurinia Pharmaceuticals
$16.75
$2.22B
7.03
37.38%
2 Buy
1 Hold
0 Sell
Moderate Buy
Protagonist Therapeutics
$150.59
$9.37B
118.91
86.06%
13 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$125.55
$10.81B
-34.88
106.10%
15 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMVT
Immunovant
29.17
5.39
22.67%
TGTX
TG Therapeutics
61.18
27.49
81.60%
VRDN
Viridian Therapeutics
24.67
1.52
6.57%
AUPH
Aurinia Pharmaceuticals
16.65
3.48
26.42%
PTGX
Protagonist Therapeutics
144.85
68.90
90.72%
KYMR
Kymera Therapeutics
126.63
66.91
112.04%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts